BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Engelmann C, Clària J, Szabo G, Bosch J, Bernardi M. Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. J Hepatol 2021;75 Suppl 1:S49-66. [PMID: 34039492 DOI: 10.1016/j.jhep.2021.01.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang Y, Liu R, Qu Y, Zhao J, Tong L, Ye S, Qin Y. Ghrelin ameliorates transformation of hepatic ischemia-reperfusion injury to liver fibrosis by blocking Smad and ERK signalling pathways, and promoting anti-inflammation and anti-oxidation effects. Transplant Immunology 2022. [DOI: 10.1016/j.trim.2022.101597] [Reference Citation Analysis]
2 Zanetto A, Campello E, Bulato C, Gavasso S, Farinati F, Russo FP, Tormene D, Burra P, Senzolo M, Simioni P. Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.03.009] [Reference Citation Analysis]
3 Zaccherini G, Tufoni M, Bernardi M, Caraceni P. Prevention of Cirrhosis Complications: Looking for Potential Disease Modifying Agents. J Clin Med 2021;10:4590. [PMID: 34640608 DOI: 10.3390/jcm10194590] [Reference Citation Analysis]
4 Duan T, Jiang HY, Ling WW, Song B. Noninvasive imaging of hepatic dysfunction: A state-of-the-art review. World J Gastroenterol 2022; 28(16): 1625-1640 [DOI: 10.3748/wjg.v28.i16.1625] [Reference Citation Analysis]
5 Grüngreiff K, Gottstein T, Reinhold D, Blindauer CA. Albumin Substitution in Decompensated Liver Cirrhosis: Don't Forget Zinc. Nutrients 2021;13:4011. [PMID: 34836265 DOI: 10.3390/nu13114011] [Reference Citation Analysis]
6 Kondo T, Macdonald S, Engelmann C, Habtesion A, Macnaughtan J, Mehta G, Mookerjee RP, Davies N, Pavesi M, Moreau R, Angeli P, Arroyo V, Andreola F, Jalan R. The role of RIPK1 mediated cell death in acute on chronic liver failure. Cell Death Dis 2021;13:5. [PMID: 34921136 DOI: 10.1038/s41419-021-04442-9] [Reference Citation Analysis]
7 Kaps L, Schleicher EM, Medina Montano C, Bros M, Gairing SJ, Ahlbrand CJ, Michel M, Klimpke P, Kremer WM, Holtz S, Boedecker-lips SC, Galle PR, Kraus D, Schattenberg JM, Labenz C, Weinmann-menke J. Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF). JCM 2022;11:2782. [DOI: 10.3390/jcm11102782] [Reference Citation Analysis]
8 Jalan R, Szabo G. New concepts and perspectives in decompensated cirrhosis. J Hepatol 2021;75 Suppl 1:S1-2. [PMID: 34039481 DOI: 10.1016/j.jhep.2020.12.008] [Reference Citation Analysis]
9 Csak T. Hepatorenal Syndrome. Clinics in Liver Disease 2022. [DOI: 10.1016/j.cld.2022.01.013] [Reference Citation Analysis]
10 Claeys W, Van Hoecke L, Lefere S, Geerts A, Verhelst X, Van Vlierberghe H, Degroote H, Devisscher L, Vandenbroucke RE, Van Steenkiste C. The neurogliovascular unit in hepatic encephalopathy. JHEP Rep 2021;3:100352. [PMID: 34611619 DOI: 10.1016/j.jhepr.2021.100352] [Reference Citation Analysis]
11 Schulz MS, Gu W, Schnitzbauer AA, Trebicka J. Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure. Transpl Int 2022;35:10108. [DOI: 10.3389/ti.2022.10108] [Reference Citation Analysis]
12 Fan K, Zan X, Zhi Y, Yang Y, Hu K, Zhang X, Zhang X, Zhao S, Chen K, Gong X, Tian R, Zhang L. Immune response gene 1 deficiency impairs Nrf2 activation and aggravates liver fibrosis in mice. Biochemical and Biophysical Research Communications 2022;607:103-9. [DOI: 10.1016/j.bbrc.2022.03.110] [Reference Citation Analysis]
13 Lamatsch S, Sittner R, Tacke F, Engelmann C. Novel drug discovery strategies for the treatment of decompensated cirrhosis. Expert Opin Drug Discov 2021;:1-10. [PMID: 34971342 DOI: 10.1080/17460441.2022.2020755] [Reference Citation Analysis]
14 Engelmann C, Herber A, Franke A, Bruns T, Schiefke I, Zipprich A, Zeuzem S, Goeser T, Canbay A, Berg C, Trebicka J, Uschner FE, Chang J, Mueller T, Aehling N, Schmelzle M, Splith K, Lammert F, Lange CM, Sarrazin C, Trautwein C, Manns M, Häussinger D, Pfeiffenberger J, Galle PR, Schmiedeknecht A, Berg T. Granulocyte-Colony Stimulating Factor (G-CSF) to treat acute-on-chronic liver failure, a multicenter randomized trial (GRAFT study). J Hepatol 2021:S0168-8278(21)01963-2. [PMID: 34364917 DOI: 10.1016/j.jhep.2021.07.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]